SECOND AMENDMENT TO MANAGEMENT SERVICES AGREEMENT
Exhibit 10.1
SECOND AMENDMENT TO
THIS SECOND AMENDMENT TO MANAGEMENT SERVICES AGREEMENT (this “Amendment”) is made effective as of April 1, 2018 (the “Amendment Effective Date”), by and between Araxes Pharma LLC, a Delaware limited liability company, having a business address at 0000 Xxxxxxx Xxxx Xxxx, Xxxxx 000, Xxx Xxxxx, XX 00000 (the “Company”), and Kura Oncology, Inc., a Delaware corporation having a business address at 0000 Xxxxxxx Xxxx Xxxx, Xxxxx 000, Xxx Xxxxx, XX 00000 (“Kura”).
WHEREAS, Company and Kura desire to amend the Management Services Agreement dated October 1, 2014 by and between Company and Kura, as amended effective as of April 1, 2016 (the “Agreement”), as set forth herein.
NOW, THEREFORE, in consideration of the various covenants and agreements hereinafter set forth, the parties agree as follows:
|
1. |
In Exhibit B, Services/Fees, Section 1A is deleted in its entirety and replaced with the following: “A.For Management Services, the Company shall pay Kura a monthly fee of $60,000.00.” |
|
2. |
Except as amended as described above, all other terms and conditions of the Agreement will remain in full force and effect. |
IN WITNESS WHEREOF, the parties have executed this Amendment by their duly authorized officers or representatives.
|
|
Araxes Pharma LLC |
|||
|
|
|
|
|
|
|
By: |
/s/ Xxxx X. Xxxxxx, Ph.D., X.X. |
|
By: |
/s/ Xxxxx Xxxxxx |
|
Name: |
Xxxx X. Xxxxxx, Ph.D., X.X. |
|
Name: |
Xxxxx Xxxxxx |
|
Title: |
President and CEO |
|
Title: |
CFO |
|
Date: |
March 29, 2018 |
|
Date: |
March 20, 2018 |
